About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[18] 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬

Disease ID	Name
13	Multiple sclerosis
15	Inclusion body myositis
19	Lysosomal storage disease
20	Adrenoleukodystrophy
36	Epidermolysis bullosa
43	Microscopic polyangiitis
44	Wegener granulomatosis
46	Malignant rheumatoid arthritis
51	Scleroderma
60	Aplastic anemia
65	Primary immunodeficiency
85	Idiopathic interstitial pneumonia
96	Crohn disease
107	Juvenile idiopathic arthritis
283	Acquired pure red cell aplasia
284	Diamond-Blackfan anemia
285	Fanconi anemia
326	Osteopetrosis

2

Alemtuzumab (already received BY alemtuzumab cohort between 1991 and 1994

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 46 💬

3

Alemtuzumab 0.2 MG

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[2] 65, 164 💬

4

Alemtuzumab 0.3 MG

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[2] 65, 164 💬

5

Alemtuzumab 12 MG

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 13 💬

6

Alemtuzumab 24 MG

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 13 💬

7

Alemtuzumab and rituximab

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 60 💬

8

Alemtuzumab GZ402673

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 13 💬

9

Alemtuzumab immunotherapy

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 13 💬

10

Alemtuzumab injection

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 13 💬

11

Alemtuzumab, rituximab

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab, Alemtuzumab) 💬

-

-

[1] 63 💬

12

Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab

-

-

-

-

[1] 13 💬

13

Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq

[1] Natalizumab

[1] Natalizumab 💬

[1] ITGA4 💬

[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬

[1] 13 💬

14

Transplant preparative regimen OF alemtuzumab, fludarabine, thiotepa, and melphalan

-

-

-

-

[2] 65, 164 💬